Your browser doesn't support javascript.
loading
Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas.
Seiwert, Tanguy Y; Zuo, Zhixiang; Keck, Michaela K; Khattri, Arun; Pedamallu, Chandra S; Stricker, Thomas; Brown, Christopher; Pugh, Trevor J; Stojanov, Petar; Cho, Juok; Lawrence, Michael S; Getz, Gad; Brägelmann, Johannes; DeBoer, Rebecca; Weichselbaum, Ralph R; Langerman, Alexander; Portugal, Louis; Blair, Elizabeth; Stenson, Kerstin; Lingen, Mark W; Cohen, Ezra E W; Vokes, Everett E; White, Kevin P; Hammerman, Peter S.
Afiliação
  • Seiwert TY; Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois. The University of Chicago Comprehensive Cancer Center, Chicago, Illinois. Institute for Genomics and Systems Biology, University of Chicago, Chicago, Illinois. tseiwert@medicine.bsd.uchicago.edu.
  • Zuo Z; Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois.
  • Keck MK; Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois.
  • Khattri A; Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois.
  • Pedamallu CS; Broad Institute of Harvard and MIT, Cambridge, Massachusetts. Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts.
  • Stricker T; Department of Pathology, Microbiology, and Immunology, Vanderbilt University, Nashville, Tennessee.
  • Brown C; Department of Genetics, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Pugh TJ; Broad Institute of Harvard and MIT, Cambridge, Massachusetts. Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts.
  • Stojanov P; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
  • Cho J; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
  • Lawrence MS; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
  • Getz G; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
  • Brägelmann J; Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois.
  • DeBoer R; Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois.
  • Weichselbaum RR; The University of Chicago Comprehensive Cancer Center, Chicago, Illinois. Department of Radiation Oncology, The University of Chicago, Chicago, Illinois.
  • Langerman A; The University of Chicago Comprehensive Cancer Center, Chicago, Illinois. Department of Otolaryngology/Head and Neck Surgery, The University of Chicago, Chicago, Illinois.
  • Portugal L; The University of Chicago Comprehensive Cancer Center, Chicago, Illinois. Department of Otolaryngology/Head and Neck Surgery, The University of Chicago, Chicago, Illinois.
  • Blair E; The University of Chicago Comprehensive Cancer Center, Chicago, Illinois. Department of Otolaryngology/Head and Neck Surgery, The University of Chicago, Chicago, Illinois.
  • Stenson K; The University of Chicago Comprehensive Cancer Center, Chicago, Illinois. Department of Otolaryngology/Head and Neck Surgery, The University of Chicago, Chicago, Illinois.
  • Lingen MW; The University of Chicago Comprehensive Cancer Center, Chicago, Illinois. Department of Pathology, University of Chicago, Chicago, Illinois.
  • Cohen EE; Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois. The University of Chicago Comprehensive Cancer Center, Chicago, Illinois.
  • Vokes EE; Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois. The University of Chicago Comprehensive Cancer Center, Chicago, Illinois.
  • White KP; The University of Chicago Comprehensive Cancer Center, Chicago, Illinois. Institute for Genomics and Systems Biology, University of Chicago, Chicago, Illinois.
  • Hammerman PS; Broad Institute of Harvard and MIT, Cambridge, Massachusetts. Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts.
Clin Cancer Res ; 21(3): 632-41, 2015 Feb 01.
Article em En | MEDLINE | ID: mdl-25056374
ABSTRACT

PURPOSE:

The genetic differences between human papilloma virus (HPV)-positive and -negative head and neck squamous cell carcinomas (HNSCC) remain largely unknown. To identify differential biology and novel therapeutic targets for both entities, we determined mutations and copy-number aberrations in a large cohort of locoregionally advanced HNSCC. EXPERIMENTAL

DESIGN:

We performed massively parallel sequencing of 617 cancer-associated genes in 120 matched tumor/normal samples (42.5% HPV-positive). Mutations and copy-number aberrations were determined and results validated with a secondary method.

RESULTS:

The overall mutational burden in HPV-negative and HPV-positive HNSCC was similar with an average of 15.2 versus 14.4 somatic exonic mutations in the targeted cancer-associated genes. HPV-negative tumors showed a mutational spectrum concordant with published lung squamous cell carcinoma analyses with enrichment for mutations in TP53, CDKN2A, MLL2, CUL3, NSD1, PIK3CA, and NOTCH genes. HPV-positive tumors showed unique mutations in DDX3X, FGFR2/3 and aberrations in PIK3CA, KRAS, MLL2/3, and NOTCH1 were enriched in HPV-positive tumors. Currently targetable genomic alterations were identified in FGFR1, DDR2, EGFR, FGFR2/3, EPHA2, and PIK3CA. EGFR, CCND1, and FGFR1 amplifications occurred in HPV-negative tumors, whereas 17.6% of HPV-positive tumors harbored mutations in fibroblast growth factor receptor genes (FGFR2/3), including six recurrent FGFR3 S249C mutations. HPV-positive tumors showed a 5.8% incidence of KRAS mutations, and DNA-repair gene aberrations, including 7.8% BRCA1/2 mutations, were identified.

CONCLUSIONS:

The mutational makeup of HPV-positive and HPV-negative HNSCC differs significantly, including targetable genes. HNSCC harbors multiple therapeutically important genetic aberrations, including frequent aberrations in the FGFR and PI3K pathway genes. See related commentary by Krigsfeld and Chung, p. 495.
Assuntos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Papillomaviridae / Infecções Tumorais por Vírus / Carcinoma de Células Escamosas / Genômica / Infecções por Papillomavirus / Neoplasias de Cabeça e Pescoço Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Papillomaviridae / Infecções Tumorais por Vírus / Carcinoma de Células Escamosas / Genômica / Infecções por Papillomavirus / Neoplasias de Cabeça e Pescoço Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article